Professor Dominic Ffytche
Professor of Visual Psychiatry
Research interests
- Ageing
- Psychiatry
Biography
Dominic Ffytche is Professor of Visual Psychiatry at the Institute of Psychiatry, Psychology & Neuroscience at King's College London. He is Lead Consultant Psychiatrist to the Visual Perceptual Disorder clinic at the South London and Maudsley NHS Foundation Trust, a national specialist service for patients with visual hallucinations.
He researches brain mechanisms of vision and how they go wrong to cause visual hallucinations, visual illusions and related symptoms and treatments for such experiences. He has published over 100 articles in the scientific and lay literature with over 4,000 academic citations.
He plays a leading role in patient and public education for Charles Bonnet Syndrome (visual hallucinations in eye disease) as medical advisor to Esme’s Umbrella and has helped develop information resources on visual hallucinations for the NHS, charity sector and eye-health professionals.
Research
Cannabidiol for Parkinson’s Disease Psychosis (CAN-PDP) Trial
Multi-centre trial of cannabidiol (CBD) for the treatment of Parkinson's disease psychosis
Project status: Ongoing
Centre for Healthy Brain Ageing
The centre supports the development of biomarkers in neurocognitive disorders, and novel strategies to support the early diagnosis of AD and related disorders.
News
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis
Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson’s disease and a potential therapeutic target
Research
Cannabidiol for Parkinson’s Disease Psychosis (CAN-PDP) Trial
Multi-centre trial of cannabidiol (CBD) for the treatment of Parkinson's disease psychosis
Project status: Ongoing
Centre for Healthy Brain Ageing
The centre supports the development of biomarkers in neurocognitive disorders, and novel strategies to support the early diagnosis of AD and related disorders.
News
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis
Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson’s disease and a potential therapeutic target